CINGOLANI, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 672
EU - Europa 375
AS - Asia 170
OC - Oceania 2
Totale 1.219
Nazione #
US - Stati Uniti d'America 669
IE - Irlanda 87
IT - Italia 82
CN - Cina 71
SE - Svezia 59
SG - Singapore 51
UA - Ucraina 42
TR - Turchia 28
FR - Francia 25
GB - Regno Unito 24
DE - Germania 22
IN - India 10
RU - Federazione Russa 10
FI - Finlandia 8
BE - Belgio 5
VN - Vietnam 4
CA - Canada 3
RO - Romania 3
AU - Australia 2
HK - Hong Kong 2
HU - Ungheria 2
IR - Iran 2
PL - Polonia 2
CZ - Repubblica Ceca 1
EE - Estonia 1
IL - Israele 1
MK - Macedonia 1
NL - Olanda 1
TW - Taiwan 1
Totale 1.219
Città #
Chandler 173
Dublin 87
Jacksonville 73
Ashburn 63
Princeton 45
Singapore 43
Chieti 35
Boardman 24
Wilmington 24
Southend 20
Altamura 19
Ann Arbor 18
Nanjing 17
Izmir 14
Beijing 12
Dearborn 12
Los Angeles 12
New York 10
Santa Clara 9
Cambridge 7
Falls Church 7
Nanchang 7
Tianjin 6
Washington 6
Brussels 4
Changsha 4
Dong Ket 4
Hebei 4
Shenyang 4
Bellante 3
Edinburgh 3
Grevenbroich 3
Jinan 3
Kunming 3
Monmouth Junction 3
Mumbai 3
Ardabil 2
Arnsberg 2
Budapest 2
Francavilla Al Mare 2
Guelph 2
Helsinki 2
Hong Kong 2
Munich 2
Ningbo 2
Pievepelago 2
Raviscanina 2
Rome 2
Woodbridge 2
Alexandria 1
Ameno 1
Amsterdam 1
Andover 1
Aprilia 1
Augusta 1
Brisbane 1
Brno 1
Changchun 1
Chicago 1
Hefei 1
Houston 1
Jiaxing 1
Lanciano 1
Lanzhou 1
Leawood 1
Nardò 1
Norwalk 1
Pescara 1
Phoenix 1
Pune 1
San Mateo 1
Seattle 1
Sesto San Giovanni 1
Shaoxing 1
Taipei 1
Tallinn 1
Tel Aviv 1
Toronto 1
Vancouver 1
Wenzhou 1
Zhengzhou 1
Totale 842
Nome #
Bronchial hyperresponsiveness to mannitol, airway inflammation and asthma control test in atopic asthmatic children 92
Airway hyper-responsiveness to mannitol provides a good evaluation of atopy in childhood asthma 91
Vitamin D supplementation modulates the immune system and improves atopic dermatitis in children 88
Usefulness of nBos d 4, 5 and nBos d 8 Specific IgE Antibodies in Cow's Milk Allergic Children 86
Evaluation of association between airway hyperresponsiveness, asthma control test, and asthma therapy assessment questionnaire in asthmatic children 84
Sensitization to timothy grass pollen allergenic molecules in children 83
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting 78
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 70
Growth failure in children with cystic fibrosis. 69
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 67
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 61
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 59
Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study 52
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 50
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 47
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 46
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART 45
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 44
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 37
“Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial” 35
Totale 1.284
Categoria #
all - tutte 5.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.779


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020119 0 0 0 0 18 18 28 12 19 6 18 0
2020/2021104 7 2 17 1 0 19 1 1 25 7 16 8
2021/2022112 3 1 1 8 7 12 7 5 12 6 12 38
2022/2023414 31 64 26 49 38 65 17 44 55 3 18 4
2023/2024209 6 3 16 4 10 62 29 26 9 9 1 34
2024/202596 15 81 0 0 0 0 0 0 0 0 0 0
Totale 1.284